$106.43 billion
The value of Pfizer’s sweetened bid for AstraZeneca—rejected by the British drug maker earlier today.
The M&A market is definitely heating up and will act as a tail wind to stock prices!
(Source: Wall Street Journal)
EWM Number of the Day: 5/2/2014
